Group targets 80% appropriate cancer treatment in Nigeria by 2030
By Lilian U. Okoro The Roche Products Ltd., says it targets to move patient’s breast cancer treatment in Nigeria from 65 per cent being inadequately treated to 80 per cent receiving appropriate treatment by 2030. The General Manager of the company, Dr Ladi Hamed, made this known at aContinue Reading




















